Why carry out this study?

Traditional glucose monitoring methods provide snapshots of blood glucose concentration and may not provide insights into all the hyper- and hypoglycemic episodes or glycemic variability. Thus, continuous glucose monitoring systems (CGMS) have emerged to address these issues.

Compared to intermittently scanned CGMS (isCGMS), real-time CGMS (rtCGMS) have been demonstrated to provide better glycemic control and quality of life in individuals with diabetes.

Hence, we evaluated the performance and safety of Glunovo® rtCGMS in monitoring interstitial fluid glucose in adult participants with diabetes.

What was learned from the study?

The Glunovo® CGMS showed high accuracy in both monitoring the real-time continuous changes and predicting the trend of changes in blood glucose level.

Along with better accuracy, Glunovo® CGMS has a sensor life of 14 days which is an added benefit compared to other CGMS on the market.